Targeting the Wnt pathways for therapies

Overview of attention for article published in Molecular and Cellular Therapies, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 121 Dimensions

Readers on

mendeley: 142 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

WNT SIGNALING AGONIST MOLECULES

Application EP-4219564-A1

European Patent Office

WNT SIGNALING AGONIST MOLECULES

Grant EP-3191526-B1

European Patent Office

METHODS OF TREATING OR INHIBITING ONSET OF HUNTINGTON'S DISEASE

Application WO-2019246262-A2

World Intellectual Property Organisation (WIPO)

WNT ANTAGONISTS AND THEIR USE IN METHODS FOR TREATING MYOCARDIAL INFARCTION

Application WO-2018083284-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.